About
Serena Kern-Libera is the co-founder and Chief Operating Officer of LinkGevity, a UK longevity biotech startup developing AI-enabled therapeutics targeting age-related degeneration. Before founding LinkGevity, she worked as a corporate M&A lawyer at Slaughter and May and later held senior public-sector roles at the Bank of England and HM Treasury. She also serves on the board of SkillSonics and has been associated with social-impact and education initiatives including the Small Countries Financial Management Centre and Discover2Dream.
Areas of interest
longevitybiotechdrug discoveryAIage-related diseasekidney diseaseeducationsocial impactmusic